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1.	 Introduc,on:	 Platelet-rich	plasma	 (PRP)	 is	blood	plasma	with	a	high	 concentra9on	of	autologous	platelets	which	
cons9tute	 an	 immense	 reservoir	 of	 growth	 factors.	 The	 clinical	 use	 of	 PRP	 is	 widespread	 in	 various	 medical	




similari9es	 and	 diﬀerences	 between	 the	 variety	 of	 PRP	




3.	 Methods:	 A	 search	 for	 ar9cles	 was	 conducted	 in	 the	
Pubmed	 and	 Pedro	 databases.	 The	 results	 were	 obtained	
by	 using	 the	 following	 key	 words	 and	 combina9ons	 of	
these	 key	 words:	 PRP,	 platelet-rich	 plasma,	 injec9on,	
treatment,	 tennis	 elbow,	 greater	 trochanteric	 pain	
syndrome,	 jumper’s	 knee,	 Achilles	 tendinopathy,	 plantar	
fascii9s,	 an9coagulant,	 sodium	 chloride,	 local	 anesthe9c,	
and	centrifuga9on	speed.	
In	 this	 literature	 review,	 we	 take	 a	 closer	 look	 at	 eight	
parameters	 which	 may	 inﬂuence	 the	 quality	 of	 PRP:	 1)	
an9coagulants	used	to	preserve	the	best	platelet	func9on,	
2)	the	speed	of	centrifuga9on	used	to	extract	the	platelets,	
3)	 the	 platelet	 concentra9ons	 obtained,	 4)	 the	 impact	 of	
the	 concentra9on	 of	 red	 and	 while	 blood	 cells	 on	 PRP	
ac9ons,	 5)	 platelet	 ac9vators	 encouraging	 platelet	
degranula9on	 and,	 hence,	 the	 release	 of	 growth	 factors,	
and	6)	the	use	or	nonuse	of	local	anesthe9cs	when	carrying	
out	 inﬁltra9on.	 In	addi9on	to	these	parameters,	 it	may	be	
interes9ng	to	analyze	other	variables	such	as	7)	the	use	of	
ultrasound	 guidance	 during	 the	 injec9on	 with	 a	 view	 to	
determining	the	inﬂuence	they	have	on	poten9al	recovery.
4.	 Results:	 Analysis	 of	 the	 59	 studies	 shows	 that	 a	
majority	 use	 ACDA	 as	 an	 an9coagulant	 during	
sampling.	A	platelet	ac9vator	(calcium	chloride)	is	only	
used	 in	a	few	studies.	However,	the	best	results	have	
been	 obtained	 in	 studies	 which	 use	 no	 platelet	
ac9vator.	 In	 terms	 of	 the	 speed	 of	 centrifuga9on,	
analysis	 of	 all	 these	 studies	 appears	 to	 conﬁrm	 the	
existence	 of	 a	 great	 number	 of	 protocols	 in	 the	
literature.	 It	 is	diﬃcult	 to	draw	any	conclusions	when	
these	 diﬀerent	 variables	 are	 unknown	 (volume	 of	
ini9al	 sample,	 equipment	 used	 to	 obtain	 the	 PRP).	
Currently,	no	studies	have	been	carried	out	neither	on	
the	use	of	a	“buﬀer”	product	to	neutralize	the	acidity	
caused	 by	 the	 an9coagulant	 nor	 on	 the	 op9mal	
volume	 of	 PRP	 to	 be	 injected.	 Although	 it	 would	
appear	 inadvisable	 to	 administer	 a	 local	 anesthe9c	
because	 the	 anesthe9c	may	 reduce	 the	 local	 pH	 and	
lead	to	the	inhibi9on,	reduc9on,	or	absence	of	platelet	
degranula9on,	 the	 literature	 shows	 that	 the	majority	
use	 a	 local	 anesthe9c.	 They	 do	 not,	 however,	 obtain	
beYer	results	than	those	not	using	a	 local	anesthe9c.	
Finally,	 it	 appears	 to	 be	 advisable	 to	 carry	 out	
inﬁltra9on	 under	 ultrasound	 guidance,	 even	 if	 PRP	
diﬀusion	 is	 observed	 a[er	 injec9on.	 This	 all	 aims	 to	
show	that	there	is	s9ll	a	need	for	high	quality	studies,	
with	standardized	collec9on	protocols	and	 the	use	of	
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